IRINOTECAN HYDROCHLORIDE + BEVACIZUMAB + LEUCOVORIN + Fluorouracil for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Nov 2011: Trial started, NCT03303495
  2. 6 Oct 2017: Trial registered, NCT03303495

The trials

NCT03303495: A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

State
Under way
Phase
Phase 3
People
280 planned
Started
14 Nov 2011
Primary completion
31 Dec 2026
Arms
FOLFIRI +/- Bevacizumab
Results
None posted
  1. 14 Nov 2011: Trial started
  2. 6 Oct 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.